Novel Peritoneal Sclerosis Rat Model Developed by Administration of Bleomycin and Lansoprazole
-
Published:2023-11-09
Issue:22
Volume:24
Page:16108
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Kunitatsu Kosei1, Yamamoto Yuta2ORCID, Nasu Shota2, Taniji Akira2, Kawashima Shuji1, Yamagishi Naoko2ORCID, Ito Takao2, Inoue Shigeaki1, Kanai Yoshimitsu2
Affiliation:
1. Department of Emergency and Critical Care Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-8509, Japan 2. Department of Anatomy and Cell Biology, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-8509, Japan
Abstract
In our preliminary experiment, peritoneal sclerosis likely induced by peritoneal dialysis was unexpectedly observed in the livers of rats given bleomycin and lansoprazole. We examined whether this peritoneal thickening around the liver was time-dependently induced by administration of both drugs. Male Wistar rats were injected with bleomycin and/or lansoprazole for 2 or 4 weeks. The 3YB-1 cell line derived from rat fibroblasts was treated by bleomycin and/or lansoprazole for 24 h. The administration of both drugs together, but not individually, thickened the peritoneal tissue around the liver. There was accumulation of collagen fibers, macrophages, and eosinophils under mesothelial cells. Expressions of Col1a1, Mcp1 and Mcp3 genes were increased in the peritoneal tissue around the liver and in 3YB-1 cells by the administration of both drugs together, and Opn genes had increased expressions in this tissue and 3YB-1 cells. Mesothelial cells indicated immunoreactivity against both cytokeratin, a mesothelial cell marker, and αSMA, a fibroblast marker, around the livers of rats given both drugs. Administration of both drugs induced the migration of macrophages and eosinophils and induced fibrosis associated with the possible activation of fibroblasts and the possible promotion of the mesothelial–mesenchymal transition. This might become a novel model of peritoneal sclerosis for peritoneal dialysis.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference38 articles.
1. The Peritoneum: What Nuclear Radiologists Need to Know;Bermo;Semin. Nucl. Med.,2020 2. The Peritoneum: Health, Disease, and Perspectives regarding Tissue Engineering and Cell Therapies;Arcanjo;Cells Tissues Organs,2017 3. Jagirdar, R.M., Bozikas, A., Zarogiannis, S.G., Bartosova, M., Schmitt, C.P., and Liakopoulos, V. (2019). Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options. Int. J. Mol. Sci., 20. 4. Masola, V., Bonomini, M., Borrelli, S., Di Liberato, L., Vecchi, L., Onisto, M., Gambaro, G., Palumbo, R., and Arduini, A. (2022). Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis. Int. J. Mol. Sci., 23. 5. Morphologic changes in the peritoneal membrane of patients with renal disease;Williams;J. Am. Soc. Nephrol.,2002
|
|